Now Live: Cboe Europe real-time data for all major European stocks.
opens in 3d 9h 18m
Market closed

Pre-market opens in 3 days 3 hours 48 minutes
Main market opens in 3 days 9 hours 18 minutes

00:11
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).
1.89000 USD
0.01
0.53%
Last update Apr 2, 3:59 PM EDT
Market closed
Day range
1.81010
1.92000
Previous close
1.88000
Open
1.85000
Access this stock data via API
Subscribe
Palisade Bio Inc.
1.89
0.01
0.53%

Overview

Access /time_series data via our API — starting from the Basic plan and above.

Description

Palisade Bio Inc. is a clinical-stage biopharmaceutical company dedicated to advancing drug therapies aimed at improving the safety and efficacy of treatments for acute and chronic gastrointestinal complications. Known for its targeted focus on enhancing surgical outcomes, Palisade Bio's primary asset is its lead investigational drug candidate, designed to mitigate intestinal permeability and reduce related post-operative complications. The company's research initiatives are significant in medical areas such as gastrointestinal diseases, underscoring its commitment to innovations that potentially benefit patient recovery and healthcare systems. By developing solutions that aim to improve patient quality of life during surgical recoveries, Palisade Bio plays a vital role in the biotechnology sector, particularly in gastrointestinal health. Headquartered in Carlsbad, California, the company's efforts contribute to the broader field of biopharmaceutical development, positioning it as a key player in addressing unmet medical needs.

About

CEO
Mr. J. D. Finley
Employees
14
Address
4600 South Syracuse Street
Suite 900
Denver, 80237, CO
United States
Phone
858 704 4900
Website
Instrument type
Common stock
Sector
Healthcare
Industry
Biotechnology
Country
United States
MIC code
XNCM
Access /profile data via our API — starting from the Grow plan (individual) and the Venture plan (business) and above.

Latest press releases

Oct 20, 2025
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Palisade Bio, Inc. (NASDAQ: PALI)

NEW YORK, Oct. 20, 2025 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating Palisade Bio, Inc. (NASDAQ: PALI) on behalf of the company's shareholders. The investigation seeks to determine whether Palisade Bio's directors breached their fiduciary duties in connection with recent corporate actions.

If you are a shareholder of Palisade Bio, Inc. and are interested in obtaining additional information about your rights and options, please visit us at: https://pjlfirm.com/palisade-bio-inc/

You may also contact Robert H. Lefkowitz, Esq. either via email at rl@pjlfirm.com or by telephone at 212-725-1000. One of our attorneys will personally speak with you about the case at no cost or obligation.

Purcell & Lefkowitz LLP is a law firm exclusively committed to representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty and other types of corporate misconduct. For more information about the firm and its attorneys, please visit https://pjlfirm.com. Attorney advertising. Prior results do not guarantee a similar outcome.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-purcell--lefkowitz-llp-announces-shareholder-investigation-of-palisade-bio-inc-nasdaq-pali-302588951.html

SOURCE Purcell & Lefkowitz LLP

Access /press_releases data via our API — starting from the Basic plan and above.
Market closed

Pre-market opens in 3 days 3 hours 48 minutes
Main market opens in 3 days 9 hours 18 minutes

00:11
00:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).